Cheviot Value Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66K Sell
1,111
-2
-0.2% -$15 ﹤0.01% 305
2025
Q4
$9.9K Sell
1,113
-43
-4% -$340 ﹤0.01% 286
2025
Q3
$7.7K Sell
1,156
-33
-3% -$324 ﹤0.01% 315
2025
Q2
$11K Sell
1,189
-232
-16% -$2.39K ﹤0.01% 280
2025
Q1
$12.4K Buy
+1,421
New +$21.9K ﹤0.01% 272
2021
Q4
Sell
-6,848
Closed -$225K 81
2021
Q3
$225K Sell
6,848
-2,122
-24% -$67.9K 0.06% 71
2021
Q2
$271K Buy
+8,970
New +$295K 0.07% 66

Other funds holding OGN

Cheviot Value Management's OGN Position: Q1 2026 in Review

Cheviot Value Management reduced its Organon & Co (OGN) stake by 0.18% in Q1 2026, selling an estimated $15 and leaving 1,111 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Cheviot Value Management first reported a position in OGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $271K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Cheviot Value Management held 1,111 shares of Organon & Co worth $6.66K as of Q1 2026.
  • Cheviot Value Management sold 2 Organon & Co shares in Q1 2026, an estimated $15.
  • Organon & Co made up ﹤0.01% of Cheviot Value Management's portfolio in Q1 2026, its #305 holding.
  • Cheviot Value Management first reported a position in Organon & Co in Q2 2021 and has held it in 7 quarters since.
  • Cheviot Value Management's Organon & Co position peaked at $271K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Cheviot Value Management's 13F filing for Q1 2026, filed 12 May 2026.